Skip to main content
An official website of the United States government

Lymphoma Steering Committee Roster

The Lymphoma Steering Committee (LYSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult lymphoma. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The LYSC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.

 

Co-chairs

Steve Ansell, M.D., Ph.D.
Mayo Clinic
Rochester, MN

Alex Herrera, M.D.
City of Hope
Duarte, CA

Kristie A. Blum, M.D. [Chair Emeritus]
Emory University Winship Cancer Center
Atlanta, GA

 

Members

Tareq Al Baghdadi, M.D.
St. Joseph Mercy Hospital
Ypsilanti, MI

Carl Allen, M.D., Ph.D.
Baylor College of Medicine
Houston, TX

Richard F. Ambinder, M.D., Ph.D.
Johns Hopkins University
Baltimore, MD

Nancy Bartlett, M.D.
Washington University School of Medicine
St. Louis, MO

Timothy Fenske, MD
Medical College of Wisconsin
Milwaukee, WI

Christopher Flowers, M.D., M.S., FASCO
University of Texas MD Anderson Cancer Center
Houston, TX

Boris Freidlin, Ph.D.
National Cancer Institute
Bethesda, MD

Jonathan Friedberg, M.D., M.M.Sc.
University of Rochester Medical Center
Rochester, NY

Meghan Gutierrez, B.A.
Lymphoma Research Foundation
New York, NY

Tricia Hernandez, M.S.
Leukemia and Lymphoma Society
New York, NY

Bradford S. Hoppe, M.D., M.P.H.
Mayo Clinic 
Jacksonville, FL

Brad Kahl, M.D.
Washington University School of Medicine
St. Louis, MO

Lale Kostakoglu, M.D.
New York University Langone Medical Center 
New York, NY

John Kuruvilla, M.D., FRCP
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada

Michael LeBlanc, Ph.D.
Fred Hutchinson Cancer Research Center
Seattle, WA 

John P. Leonard, M.D.
Weill Cornell Medical Center
New York, NY

Richard Little, M.D.
National Cancer Institute
Bethesda, MD

Peter Martin, M.D.
Weill Cornell Medical Center
New York, NY

Alison Moskowitz, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY

Ryotaro Nakamura, M.D.
City of Hope 
Duarte, CA

Chelsea C. Pinnix, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, TX

Mei-Yin C. Polley, Ph.D.
University of Chicago
Chicago, IL

Carlos Almeida Ramos, M.D.
Baylor College of Medicine
Houston, TX

Mark Roschewski, M.D.
National Cancer Institute
Bethesda, MD

Kerry Savage, M.D.
University of British Columbia
Vancouver, BC, Canada

Anurag K. Singh, M.D.
University of Kansas Medical Center
Westwood, KS

Sonali Smith, M.D.
The University of Chicago
Chicago, IL

Diego Villa Restrepo, M.D., M.P.H.
University of British Columbia
Vancouver, BC, Canada

NCI CCCT Program Director

Elena Schwartz, Ph.D.
elena.schwartz@nih.gov

 

  • Updated:
Email